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Background: Isolated acute dissection of the abdominal aorta is an unusual event that may present with several different
clinical scenarios. Because its incidence is low, the natural history is unknown. We report data from the International
Registry of Acute Aortic Dissection (IRAD), the largest group of patients treated for acute aortic dissections. The aim of
this study was to identify clinical characteristics, therapeutic approaches, risk factors for mortality, in-hospital outcome,
and long-term results of this cohort, thus clarifying its natural history.
Methods: A comprehensive analysis of 290 clinical variables on 18 patients affected by isolated acute abdominal aortic
dissection (IAAAD) was performed. Among 1417 patients enrolled in the IRAD from 1996 to 2003, 532 (37.5%) had
an acute type B dissection, of which 18 (1.3%) had an IAAAD. Theor mean age was 67.7  13.3 years, with a male
predominance (n  12, 67%). Aortic aneurysms pre-existed in 5 patients (28%). IAAAD was iatrogenic in 2 cases (11%).
Results: Compared with patients with type B aortic dissections, abdominal pain, mesenteric ischemia or infarction, limb
ischemia, and hypotension as initial clinical signs were significantly more frequent in patients with IAAAD, whereas chest
pain was more typical in patients with type B dissections. No neurologic symptoms, such as ischemic spinal cord damage
or ischemic peripheral neuropathy, occurred in the IAAAD cohort. The 18 IAAAD patients were medically, surgically, or
percutaneously managed in 12 (66.6%), five (27.8%), and one (5.6%) cases, respectively. The overall in-hospital mortality
rate was 5.6% (n  1). The patient who died was medically managed. No deaths were reported among patients who
underwent surgery or had an endovascular procedure, irrespective of their preoperative status. A mean follow-up of 5
years (range, 1 month to 9 years) was completed for 71% (12 of 17) of the patients. Four patients (33.3%) died during
the 9-year follow-up period. Overall survival was 93.3% 12.6% at 1 year and 73.3% 27.2% at 5 years. All patients who
died during the follow-up period had in-hospital medical management (P  .04).
Conclusions: IAAAD is a condition that may present differently compared with classic type B aortic dissections. IAAAD
patients treated with surgical or endovascular procedures had a lower unadjusted in-hospital and long-termmortality rate
compared with medically managed patients. On the basis of the present natural history report, continued surveillance
appears mandatory. To improve the life expectancy of patients with IAAAD, aggressive surgical or endovascular
management seems justified. (J Vasc Surg 2007;46:913-9.)Isolated acute abdominal aorta dissection (IAAAD)
is a rare event, usually related to spontaneous, traumatic,
or iatrogenic causes,1-3 The clinical presentation of
IAAAD may be associated with abdominal pain, visceral
ischemia, acute renal failure, and limb ischemia.1-4
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doi:10.1016/j.jvs.2007.07.030We report data from the International Registry of
Acute Aortic Dissection (IRAD). These data represent a
unique opportunity to study the largest group of consec-
utive patients treated for aortic dissection by 18 aortic
referral centers throughout the world. The aim of this
study was to clarify the natural history of this specific
cohort, identifying clinical characteristics, therapeutic
approaches, risk factors for mortality, in-hospital out-
come, and long-term results. Also documented were
differences in demographic, history, clinical presenta-
tion, diagnostic imaging findings, indication for surgical
or endovascular treatment, and in-hospital management
compared with the classic type B dissection.
METHODS
Patient selection. Patients having IAAAD enrolled
in the IRAD between January 1, 1996, and December
31, 2003 were included in the present analysis. IRAD is
an ongoing multinational multicenter registry started in
1996 that includes patients with acute aortic dissection
at 18 large IRAD referral centers (Appendix, online
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excludes patients with traumatic dissections, has previ-
ously been described.5
IAAAD was defined as any acute aortic dissection
involving the aorta below the diaphragm only and pre-
senting  14 days of symptom onset.5,6 Intramural he-
matoma (IMH), defined as presence of a regionally
thickened aortic wall in the absence of evidence of a
double lumen or intimal flap, or both, regardless of
imaging modality,7 was also considered in the study
cohort. A comprehensive analysis of 290 clinical vari-
ables was completed on patients classified as having
spontaneous or iatrogenic IAAAD. At each enrolling
hospital, study investigators obtained approval from
their ethics committee or institutional review board to
participate in IRAD and its follow-up study.
Data collection. Data were collected prospectively
after presentation or retrospectively from hospital
records using a standardized data form of 290 clinical
variables, including patient demographics, history, clin-
ical presentation, physical findings, imaging studies,
medical and surgical management, in-hospital mortality,
and adverse events. Yearly follow-up data were obtained
after discharge using a standardized form that includes
clinical, imaging, and vital signs data. Completed data
forms were forwarded to the coordinating center at the
University of Michigan. Data forms were reviewed for
analytical internal validity and scanned electronically into
an Access database (Microsoft Corp, Redmond, Wash).
For this analysis, 18 patients with isolated acute aortic
dissection confined to the subdiaphragmatic aortic level
were analyzed. Long-term follow up was completed on
71% of the enrolled patients.
Imaging. IAAAD was identified using one diagnos-
tic examination in 16.7% (n  3) of patients or two or
more in 83.3% (n  15). Computed tomography (CT)
imaging was used in 16 patients (88.9%), being used as
first diagnostic exam in 13 (72.2%), and an angiogram
was used in nine (50%), of which in two it was first exam.
Magnetic resonance imaging (MRI) was used in four
patients, as was ultrasound imaging, which was the first
diagnostic method in three patients. Involvement of
visceral or renal arteries was specifically evidenced with
diagnostic examinations in five patients (MRI, 2; spiral
CT, 2; ultrasound, 1). Among this cohort, one patient
was treated surgically after presenting with visceral and
limb ischemia. All of these patients were discharged from
the hospital.
Statistical analysis. Data are shown as frequencies
and percentages, and mean  standard deviation or as a
median (interquartile range). Missing data were not
defaulted to negative, and denominators reflect only
reported cases. Associations of death among nominal
variables were compared using the 2 test and the Fisher
exact test, when appropriate, and among continuous
variables using the Student t test. Long-term survival
using Kaplan-Maier methods was reported.RESULTS
Patient population. Of 1417 patients with IAAAD
enrolled in IRAD from 1996 to December 2003, 885
(62.5%) had a type A dissection and 532 (37.5%) had a
type B dissection, and 18 of these patients (1.3%) had an
acute IAAAD. They were compared with 514 patients
with classic type B dissection. The mean age in the
IAAAD cohort was 67.7  13.3 years, with men pre-
dominating (n 12, 67%). Thirteen patients (72%) were
transferred to an IRAD center from a referral hospital for
definitive treatment.
History of hypertension was present in 14 patients
(78%), pre-existing atherosclerosis in seven (41%), and
diabetes in one (5.6%). An aortic aneurysm repair was
previously performed in five patients (28%). Five patients
had an abdominal aortic graft replacement, and one
patient had a previous femorofemoral bypass Dacron
graft. The extent of aneurysm repair was unavailable
from the database.
IAAAD was considered to be an iatrogenic compli-
cation of a cardiac catheterization in two patients (11%).
None of the patients in the IAAAD cohort had Marfan
syndrome. In addition, none of the patients sustained
any prior aortic dissection or had undergone aortic re-
placement for aneurysm or dissection (Table I).
Presenting and diagnostic signs and symptoms.
Abdominal pain (P  .01), mesenteric ischemia or in-
farction (P  .03), and limb ischemia (P  .04) were
significantly more frequent in the IAAAD cohort than in
the group with type B dissection. In IAAAD, a clinical
hypertensive state (systolic blood pressure  150/90
mmHg) appeared at presentation in nine patients (53%).
Hypotension (systolic blood pressure 90/60 mmHg)
was not initially detected in the total cohort, but ap-
peared in 2 patients during hospitalization. This condi-
tion was more often present in IAAAD patients (P .03;
Table II). A CT scan was used to detect the abdominal
dissections in 16 patients (88.9%), and its use was ini-
tially adopted as the first diagnostic exam in 13 (72.2%).
Involvement of visceral or renal arteries was present in
five patients: the diagnosis was made with MRI in two,
spiral CT in two, and ultrasound imaging in one.
An aortic aneurysm was detected in seven patients
(41%). An intramural hematoma was detected in 1 pa-
tient (6%), and findings of patent, partial thrombosis, or
complete thrombosis of the false lumen were evidenced
in 9 (53%), 6 (35%), and 2 (12%) patients, respectively
(Table II). Surgical or endovascular interventions were
performed for aortic rupture, visceral ischemia, limb
ischemia, acute renal failure, extension of dissection
compromising additional arteries, recurrent or refractory
pain, or both, and untreatable hypertension (Table III).
In almost half of the invasively treated patients, more
than one indication (mean, 2.3) was reported. Three
patients with IAAAD presented with visceral ischemia,
and surgical aortic replacement was performed in two.
An aortic fenestration affecting the visceral segment was
.2)
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abdominal aortic endograft.
Management. Management of IAAAD patients was
medical in 12 (66.6%), surgical in five (27.8%) and
percutaneous in one (5.6%). Initial medical therapy was
with a -blocker in 15 patients (88%) and nitroprusside
and a calcium-channel blocker in four (27%). Vasodila-
tors were more commonly used in type B dissections
(P  .01), but were also used in three IAAAD patients
(19%). Vasopressors were needed in one patient (7%)
that was surgically treated. An abdominal aortic dissec-
tion developed during cardiac catheterization in a sec-
ond patient with hypotension. He was treated medically,
Table I. Demographics and history of patients with abdom
Variable*
Demographics
Age, y (mean  SD)
Male gender
Transferred
Etiology, patient history
Hypertension
Athersclerosis
Diabetes
Previous aortic aneurysm repair
Iatrogenic dissection
Marfan syndrome
Prior aortic dissection
Prior aortic replacement for aneurysm and/or dissection
Previous surgical coronary revascularization
*Categoric data are expressed as number (percentage)
Table II. Clinical characteristics and diagnostic imaging fi
Variables, No. (%)
Abdomina
(n 
Characteristics of pain
Abrupt onset of pain 14 (8
Back pain 10 (6
Chest pain 7 (4
Abdominal pain 11 (6
Leg pain 3 (2
Clinical signs
Mesenteric ischemia or infarction 3 (2
Acute renal failure 2 (1
Pulse deficit 5 (2
Limb ischemia 4 (2
Ischemic spinal cord damage 0 (0
Syncope 1 (5
Hypertensive 9 (5
Hypotension 2 (1
Any diagnostic test showed
Aortic aneurysm 7 (4
Intramural hematoma 1 (5
Patent false lumen thrombosis 9 (5
Partial false lumen thrombosis 6 (3
Complete false lumen thrombosis 2 (1
Periaortic hematoma 1 (6but died 2 days latter of cardiac-related complications.Among the six patients who had invasive therapy, proce-
dures were delayed beyond the day of presentation in
three cases, with a medium observed interval time be-
tween the onset of symptoms and the treatment of 14
days: two patients had refractory hypertension not re-
sponsive to maximal medical therapy with pain, and one
presented with excessive comorbidities (Table III).
The abdominal aorta was replaced in five patients,
and one patient also had a surgical peripheral vessel
management. Aortic stenting with fenestration was per-
formed in one patient. No reoperations were required.
Hospital outcomes. The overall in-hospital mortal-
ity was 5.6% (n  1). Considering the limited number of
l aortic dissection
Abdominal dissection
(n  18)
Type B dissection
(n  514) P
67.7  13.3 64.0  13.6 .15
12 (66.7) 355 (69.1) .82
13 (72.2) 337 (67.8) .69
14 (77.8) 391 (76.9) .93
7 (41.2) 180 (35.8) .65
1 (5.6) 33 (6.5) .86
5 (27.8) 92 (18.3) .3
2 (11.1) 11 (2.3) .07
0 (0.0) 18 (3.5) .41
0 (0.0) 42 (8.3) .2
0 (0) 70 (14.2) .15
2 (11.1) 21 (4.3) .19
gs of patients with abdominal aortic dissection
ction Type B dissection
(n  514) P
430 (86.0) .72
339 (67.6) .66
365 (72.1) .01
176 (35.8) .01
42 (8.7) .12
22 (4.7) .03
57 (12.1) .7
82 (17.8) .22
36 (7.7) .04
16 (3.2) .99
18 (3.6) .48
342 (68.1) .15
14 (2.8) .03
162 (35.5) .61
61 (12.4) .71
185 (46.2) .58
160 (40.0) .69
55 (13.7) .99
88 (18.5) .32inandin
l disse
18)
2.4)
2.5)
1.2)
8.7)
1.4)
1.4)
3.3)
9.4)
5.0)
.00)
.9)
2.9)
1.8)
1.2)
.6)
2.9)
5.3)
1.8)patients, no variables were significantly associated with
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cardiographic (ECG) signs suggestive of a prior myocar-
dial infarction. This patient sustained an iatrogenic dis-
section during cardiac catheterization, associated with
limb ischemia and hypotension. He was medically man-
aged, but died 2 days after this event. No deaths were
reported among patients who underwent a surgical or
endovascular procedure, irrespective of their preopera-
tive status. Mean hospital length of stay for survivors was
16.9 days: 12.9 days for patients medically managed, and
25 days for those treated surgically. Among IAAAD
patients who survived, 88% were discharged with
-blocker therapy, and 60% received calcium-channel
blockers. Angiotensin-converting enzyme inhibitors and
other vasodilators were more often recommended in
those with type B dissection (P  .01 and P  .03,
respectively).
Follow-up. In IRAD, a yearly follow-up is con-
ducted with ultrasound scan, CT scan, or MRI and
aortogram, depending on the center. Median follow-up
was completed on 71% (12 of 17) of discharged surviving
patients, and averaged 5 years, (range, 1 month to 9
years). Four patients died (33%) during the 9-year fol-
low-up period. The mean survival rate was 93%  13% at
1 year and 73%  27% at 5 years.
In two patients, death occurred after 1 month and
5.1 years, respectively, and was related to complications
from the abdominal dissection. In particular, one patient
died 1 month after hospital discharge. She originally
Table III. In-hospital management, indications for treatm
abdominal aortic dissection
Variable, No. (%)
Management
Medical
Surgical
Percutaneous
Indication for surgical or endovascular treatment
Aortic rupture
Visceral ischemia
Acute renal failure
Limb ischemia
Extension of dissection into visceral and/or renal arteries
Recurrent and/or refractory pain
Untreatable hypertension
Initial medical therapy
-Blocker
Nitroprusside
Calcium channel blocker
Vasodilator
Vasopressor
Delayed procedures
Chronic medical therapy at time of discharge
-Blocker
Calcium channel blocker
Vasodilator
Angiotensin-converting enzyme inhibitorpresented with an ischemic lower limb, acute renal fail-ure, signs of mesenteric ischemia, and ECG finding of
ischemia. She was managed in-hospital with -blockers
and calcium-channel blockers, and was discharged to
home after 9 days in stable condition. After 1 month,
however, she had a second acute hospitalization for
issues related to an incident dissection with worsening
acute renal failure. Two other patients died of unknown
causes at 1.6 and 7.5 years. Recurrence of new symptoms
or abdominal pain was observed in 1 patient and did not
correlate with late death. No further aortic enlargement
was reported.
All patients who died during the follow-up period
had in-hospital medical management alone (Fig). The
patients who died in follow-up were more likely to be
older (mean age, 71 years), to have a known aortic
aneurysm (2 of 4), to have a history of hypertension (3 of
4) and atherosclerosis (2 of 4), and to have an altered
ECG (3 of 4), with two of those showing signs of
ischemia. One of the patients who died during follow-up
was the only IAAAD patient with a history of diabetes.
DISCUSSION
IAAADs are a rare event. In the current series, 1.3%
of all IRAD enrolled patients were identified as having an
IAAAD, and previous reports have confirmed the low
incidence of the disease.1-4 A recent review of the liter-
ature by Farber et al1 in 2004 yielded only 51 patients
with this segmental dissection. Because of the large size
of the IRAD database, the present experience represents
, and long-term medical therapy of patients with
Abdominal dissection
(n  18)
Type B dissection
(n  514) P
12 (66.6) 358 (69.7) .79
5 (27.8) 85 (16.5) .21
1 (5.6) 71 (13.8) .31
1 (5.6) 21 (4.2) .79
3 (21.4) 30 (33.3) .18
2 (13.3) 72 (15.2) .99
4 (23.5) 25 (29.4) .17
3 (40.0) 65 (54.6) .66
5 (31.2) 55 (50.4) .99
1 (16.6) 21 (26.6) .99
15 (88.2) 394 (80.1) .55
4 (26.7) 190 (40.3) .28
4 (26.7) 124 (28.4) 1
3 (18.8) 229 (50.4) .01
1 (6.7) 16 (3.7) .45
3 (50.0) 89 (63.1) .67
14 (87.5) 401 (88.3) .99
9 (60.0) 266 (61.9) .99
1 (6.7) 142 (34.3) .03
2 (13.3) 217 (50.8) .01entsthe largest series reported in the literature.
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was present in more than two-thirds of the patients,
similar to rates of type A5 and B8 acute aortic dissections.
However, atherosclerosis was present more often in the
IAAAD compared with type B, as was the incidence of
iatrogenic origin.8 In the IRAD IAAAD experience, two
patients sustained a dissection of iatrogenic origin during
a cardiac catheterization. Both had a history of athero-
sclerosis and ischemic cardiac disease, and one died in the
hospital. Perhaps patients with atherosclerosis more fre-
quently develop an iatrogenic dissection secondary to
irregular calcifications in the aortic intimal wall.9,10 In
such patients, the presence of associated cardiac comor-
bidities could compromise the chances for a positive
outcome, regardless of medical or surgical management.
An association with abdominal aneurysms was de-
tected in 28% of the IRAD IAAAD patients, similar to
other experiences.1 Aortic dilatation can be the conse-
quence of an aortic dissection and seems not associated
with specific new symptoms.1,10-12 Detection of an aor-
tic aneurysm is associated with invasive therapy,3,4,13
although in IRAD it was not associated with increased
in-hospital mortality. No deaths occurred among the five
IRAD IAAAD patients who had an aortic repair; how-
ever, one had a contained ruptured with periaortic he-
matoma that was complicated by hypotension. In the
IRAD IAAAD group, periaortic hematoma was detected
in one patient (6.2%), while it was present in 19% in the
overall IRAD type B group, and was associated with a
32.4% mortality rate.14 It appears reasonable that the
coexistence of IAAAD and AAA leads to higher risk for
aortic rupture.3,4,13
As expected, patients presenting with hypotension or
shock have a poorer outcome. It was 12% in IAADS in
IRAD, lower than the rate of 17% to 28% experienced in
other groups.1,3,4,15 This high-risk condition was ob-
served in two patients, one of which had an iatrogenic
Kaplan-Meier survival curve for patients presenting with isolated
acute dissection of the abdominal aorta. *Denotes standard error
that exceeds 10%.dissection during cardiac catheterization and didn’t sur-vive, whereas the second patient had a ruptured aortic
aneurysm that was successfully operated on. As IRAD
previously reported in type A and B aortic dissections,
the presence of shock is associated with a high mortality,
regardless of the treatment choice. The presence of
shock obviously may create a bias in evaluating therapeu-
tic options because patient survival is so limited.15,16
The proximal entry site of the dissection in IAAAD
has been observed mostly below the origin of the renal
arteries,1-4 with leg ischemia present in 19% of cases.1,3
In the IRAD IAAAD cohort, it is not possible to estimate
if the proximal entry tear was above or below the renal
arteries, but a detection of distal ischemia was often
present. However, in IRAD, the IAAAD patients had
more complex with clinical presentations that included
mesenteric ischemia/infarction and acute renal failure.
Medical therapies were adopted in two-thirds of
patients and surgical therapies in one-third. One patient
died in-hospital 2 days after an iatrogenic IAAAD, and
another died 1 month after hospital discharge. Both had
been medically managed for the presence of ischemic
cardiac comorbidities. Abdominal aortic surgery in
IAAAD resulted in better results compared with those of
thoracic or thoracoabdominal aortic replacement for
acute type B dissections, where IRAD recently showed a
29% in-hospital mortality rate.16 This observation sup-
ports a more aggressive invasive surgical or endovascular
approach in patients with IAAAD compared with those
with a classic type B dissection. Standard surgical abdom-
inal aortic replacement or endovascular management
might be performed in those IAAAD patients who are
extremely complicated or who have excessive comorbidi-
ties, in which invasive management is not considered, as
IRAD showed for those having ischemic cardiac diseases.
In this latter group surgery is often contraindicated.
IRAD IAAAD long-term survival showed that the
follow-up mortality rates are high in patients discharged
from the hospital, approaching 33% of patients within 8
years. Similar to that for descending thoracic aortic
dissection,17-19 30% to 60% of follow-up deaths are from
aortic-related complications such as rupture, extension
of dissection, and perioperative mortality from subse-
quent repairs.18,19 All IRAD IAAAD patients who died
during follow-up received in-hospital medical manage-
ment, and all were medically treated to lower heart rate,
blood pressure, and inotropy. No late deaths or aortic
complications were observed among the six patients who
were invasively treated with surgery or an endograft.
Our study did not contain complete information on
cause-specific mortality; however, similar to type B dis-
sections, we observed that comorbidities, such as a his-
tory of atherosclerosis and a diseased aorta (ie, aneu-
rysm) are associated with an accelerated mortality seen
during follow-up.19,20 Although IRAD is an observa-
tional registry and therefore indications for treatment are
not supported from randomized controls, observations
from this database could be helpful for physicians who
encounter this condition. Data from IRAD suggest the
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clinical conditions should involve prompt surgical or
endovascular treatment.
Although not supported because of the small sample
size, we suggest that an endovascular approach should be
considered primarily in the presence of comorbidities
such as a history of ischemic cardiac diseases. In stable
patients, initial therapy with a -blocker is recom-
mended, followed by serial follow-up using spiral CT or
MRI of the proximal intimal tear and the distal re-entries
to consider the technical feasibility of endograft therapy.
In the patients with anatomic contraindications to endo-
vascular repair, standard surgical abdominal aortic re-
placement with extension into iliac or femoral arteries
can be performed safely. The use of -blockers can be
recommended on the basis of the long-term IRAD re-
sults with acute type A and B dissections.20,21 All of these
patients, regardless the type of dissection and the in-
hospital management, should be followed up at least
yearly with imaging of the dissection.
Limitations. IRAD is an observational series of pa-
tients treated in tertiary referral centers, and therefore,
its findings may not necessarily be applicable to the total
population. In-hospital death is the outcome variable
that was assessed in this registry analysis, and it is not
sufficient for a full evaluation of outcomes of patients
with IAAAD, which should also take into consideration
nonfatal adverse events, patient functional status, and
use of resources. IRAD has no standard protocol for
diagnosis, management, or imaging of dissections, and
treatments therefore reflect individual approaches.
In addition, all IRAD IAAAD patients in the present
study were symptomatic; therefore this study does not
lend insight in how to manage the asymptomatic patient
with an incidentally discovered IAAAD.
Finally, we only had information on follow-up mor-
tality and did not have information on all cause of death.
We were also unable to evaluate other end points such as
freedom from reoperation, rupture, or redissection.
CONCLUSIONS
IAAAD is a rare condition that presents with signif-
icant clinical variability. In the IRAD population, some
complications, such as abdominal pain, mesenteric isch-
emia or infarction, and limb ischemia, were more fre-
quent in patients with IAAAD compared with patients
with type B dissection.14,16,20 In the present IRAD
experience, IAAAD patients treated with surgical or
endovascular procedures had a lower mortality, both
in-hospital and at long-term, compared with those pa-
tients who had medical management.
The natural history of IRAD IAAAD suggests that
these patients present similarly to type B dissections,
particularly in terms of factors associated with long-term
risk of death. This observation leads to the recommen-
dation for serial CT scan surveillance.AUTHOR CONTRIBUTIONS
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